{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:00:19Z","timestamp":1791468019766,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research","doi-asserted-by":"publisher","award":["SUG-2024-1119"],"award-info":[{"award-number":["SUG-2024-1119"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuroscience.2026.06.033","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:46:29Z","timestamp":1782229589000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bromodomain protein 4 (BRD4) as a central epigenetic regulator in neuropsychiatric and neurodegenerative disorders"],"prefix":"10.1016","volume":"611","author":[{"given":"Preeti P.","family":"Bhagat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisha G.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini R.","family":"Shirasath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-3318","authenticated-orcid":false,"given":"Sanjay N.","family":"Awathale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.06.033_bib411","doi-asserted-by":"crossref","unstructured":"Amirnasr A, Verdijk RM, van Kuijk PF, Taal W, Sleijfer S, Wiemer EAC. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors. PLoS One. 2017;12(8):e0183155. Published 2017 Aug 15. doi:10.1371\/journal.pone.0183155.","DOI":"10.1371\/journal.pone.0183155"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0010","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1101\/gad.239962.114","article-title":"Double-bromo and extraterminal (BET) domain proteins regulate dendrite morphology and mechanosensory function","volume":"28","author":"Bagley","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cge.12499","article-title":"Cornelia de lange syndrome","volume":"88","author":"Boyle","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0020","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","article-title":"Autism risk factors: genes, environment, and gene-environment interactions","volume":"14","author":"Chaste","year":"2012","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116747","article-title":"Association of histone modification with the development of schizophrenia","volume":"175","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2023.12.002","article-title":"Latent-state and model-based learning in PTSD","volume":"47","author":"Cisler","year":"2024","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.033_bib406","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/acs.jmedchem.1c01779","article-title":"A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes","volume":"65","author":"Cui","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2026.06.033_bib405","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.1021\/acs.jmedchem.2c01357","article-title":"Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites\u2500Halogenated Probes of Druglike and Peptide-like Molecular Interactions","volume":"65","author":"Davison","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-025-03449-9","article-title":"Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis","volume":"22","author":"Dey","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/20974","article-title":"Structure and ligand of a histone acetyltransferase bromodomain","volume":"399","author":"Dhalluin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106767","article-title":"BRD4: New hope in the battle against glioblastoma","volume":"191","author":"Duan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.conb.2009.05.009","article-title":"Epigenetic influences on brain development and plasticity","volume":"19","author":"Fagiolini","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0070","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/s41467-022-29922-0","article-title":"Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia","volume":"13","author":"Farrelly","year":"2022","journal-title":"Nat. Commun."},{"issue":"7327","key":"10.1016\/j.neuroscience.2026.06.033_b0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102323","article-title":"Bromodomain inhibitors and therapeutic applications","volume":"75","author":"Gajjela","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0085","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","volume":"112","author":"Garton","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12808","article-title":"Role of BRD4 phosphorylation in the nucleus accumbens in relapse to cocaine-seeking behavior in mice","volume":"25","author":"Guo","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0095","doi-asserted-by":"crossref","first-page":"107383","DOI":"10.1016\/j.nlm.2021.107383","article-title":"Brd4 participates in epigenetic regulation of the extinction of remote auditory fear memory","volume":"179","author":"Huang","year":"2021","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0100","doi-asserted-by":"crossref","first-page":"1281401","DOI":"10.3389\/fnins.2023.1281401","article-title":"The neural circuits and molecular mechanisms underlying fear dysregulation in posttraumatic stress disorder","volume":"17","author":"Iqbal","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0105","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1093\/nar\/gku449","article-title":"Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation","volume":"42","author":"Itzen","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nlm.2004.05.008","article-title":"Inducible repression of CREB function disrupts amygdala-dependent memory","volume":"82","author":"Josselyn","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.033_b0120","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/hmg\/ddu002","article-title":"Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance","volume":"23","author":"Kaiser","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.033_b0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nsmb.2912","article-title":"BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones","volume":"21","author":"Kanno","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0130","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nn.4095","article-title":"BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice","volume":"18","author":"Korb","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cell.2017.07.033","article-title":"Excess translation of epigenetic regulators contributes to Fragile X Syndrome and is alleviated by Brd4 inhibition","volume":"170","author":"Korb","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0140","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.tins.2022.06.001","article-title":"BET-ting on histone proteomics in schizophrenia","volume":"45","author":"Kundakovic","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0145","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170216","article-title":"Rett syndrome: a neurological disorder with metabolic components","volume":"8","author":"Kyle","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0150","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1111\/ene.15360","article-title":"The contribution of neuropathology to multiple sclerosis research","volume":"29","author":"Lassmann","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0160","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.3390\/ijms27052268","article-title":"Targeting BRD4\u2014a promising therapeutic option for glioblastoma?","volume":"27","author":"Lindner","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-023-00625-4","article-title":"ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer\u2019s disease","volume":"18","author":"Lin","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0170","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.cell.2013.10.056","article-title":"Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release","volume":"155","author":"Liu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.748449","article-title":"Role of BET proteins in inflammation and CNS diseases","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0175","first-page":"1440","article-title":"Non-classic cornelia de lange syndrome due to BRD4 gene alterations: a literature review","volume":"12","author":"Lonardo","year":"2025","journal-title":"Children (basel)"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","article-title":"Demyelination in multiple sclerosis","volume":"122","author":"Lubetzki","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.033_b0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41419-019-1792-x","article-title":"The Cornelia de Lange Syndrome-associated factor NIPBL interacts with BRD4 ET domain for transcription control of a common set of genes","volume":"10","author":"Luna-Pel\u00e1ez","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0190","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.3390\/ijms222212280","article-title":"Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer\u2019s disease","volume":"22","author":"Maity","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0195","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euroneuro.2024.02.010","article-title":"Parvalbumin interneuron deficits in schizophrenia","volume":"82","author":"Mar\u00edn","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s11689-021-09362-5","article-title":"Autism spectrum disorder in females with fragile X syndrome: a systematic review and meta-analysis of prevalence","volume":"13","author":"Marlborough","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0210","doi-asserted-by":"crossref","first-page":"27176","DOI":"10.1074\/jbc.271.43.27176","article-title":"Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase","volume":"271","author":"Marshall","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0215","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/biomedicines11030750","article-title":"Bromodomain and extra-terminal proteins in brain physiology and pathology: BET-ing on epigenetic regulation","volume":"11","author":"Martella","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0220","article-title":"Epigenetic regulation in neuroplasticity: key to understanding and treating neurological diseases","volume":"41","author":"Minal","year":"2025","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0225","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/sj.onc.1210618","article-title":"Structure and acetyl-lysine recognition of the bromodomain","volume":"26","author":"Mujtaba","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41593-018-0101-9","article-title":"Dysregulation of the epigenetic landscape of normal aging in Alzheimer\u2019s disease","volume":"21","author":"Nativio","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.033_bib404","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1248\/cpb.c16-00225","article-title":"BET Bromodomain as a Target of Epigenetic Therapy","volume":"64","author":"Noguchi-Yachide","year":"2016","journal-title":"Chemical and Pharmaceutical Bulletin"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.033_bib410","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41588-018-0042-y","article-title":"BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange-like syndrome","volume":"50","author":"Olley","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0235","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1037\/bul0000014","article-title":"Effects of sleep on memory for conditioned fear and fear extinction","volume":"141","author":"Pace-Schott","year":"2015","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/biom11010075","article-title":"Role of DNA methyl-CpG-binding protein MeCP2 in Rett syndrome pathobiology and mechanism of disease","volume":"11","author":"Pejhan","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0245","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ng.3550","article-title":"Histone H3 globular domain acetylation identifies a new class of enhancers","volume":"48","author":"Pradeepa","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0250","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41420-023-01775-6","article-title":"Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets","volume":"9","author":"Qian","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13148-021-01039-z","article-title":"BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS\/FTD model","volume":"13","author":"Quezada","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.033_bib408","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1535-7163.MCT-16-0141","article-title":"AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies","volume":"15","author":"Rhyasen","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0260","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12974-015-0470-x","article-title":"Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer\u2019s disease pathology","volume":"13","author":"Rosenberger","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.033_bib407","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ejh.13525","article-title":"Targeting both BET and CBP\/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma","volume":"106","author":"Ryan","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jmedgenet-2019-106277","article-title":"Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach","volume":"57","author":"Sarogni","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0270","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s13311-013-0204-7","article-title":"Acetyltransferases (HATs) as targets for neurological therapeutics","volume":"10","author":"Schneider","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0275","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108306","article-title":"BET bromodomains as novel epigenetic targets for brain health and disease","volume":"181","author":"Singh","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112646","article-title":"A novel PROTAC molecule dBET1 alleviates pathogenesis of experimental autoimmune encephalomyelitis in mice by degrading BRD4","volume":"139","author":"Song","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0290","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.3390\/ijms23168972","article-title":"The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.033_bib409","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2023.11.006","article-title":"Unlocking the secrets of aging: Epigenetic reader BRD4 as the target to combatting aging-related diseases","volume":"63","author":"Sun","year":"2024","journal-title":"J Adv Res"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","article-title":"Advancing cell therapy for neurodegenerative diseases","volume":"30","author":"Temple","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0305","doi-asserted-by":"crossref","unstructured":"Tenchov, R., Sasso, J., Zhou, Q.A., 2024. Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration. doi: 10.26434\/chemrxiv-2024-pt7wp.","DOI":"10.26434\/chemrxiv-2024-pt7wp"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0310","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2013.01.032","article-title":"Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer","volume":"152","author":"Tropberger","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0315","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.3390\/ijms232314575","article-title":"Mechanisms of susceptibility and resilience to PTSD: role of dopamine metabolism and BDNF expression in the hippocampus","volume":"23","author":"Tseilikman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0320","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.033_bib402","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1021\/jm4011302","article-title":"Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening","volume":"56","author":"Vidler","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.100993","article-title":"Exerkines and long-term synaptic potentiation: mechanisms of exercise-induced neuroplasticity","volume":"66","author":"Vints","year":"2022","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0330","doi-asserted-by":"crossref","first-page":"36547","DOI":"10.1074\/jbc.M109.033712","article-title":"Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution","volume":"284","author":"Vollmuth","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.033_bib412","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jnc.15439","article-title":"Inhibiting Brd4 alleviated PTSD-like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats","volume":"158","author":"Wang","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0340","first-page":"1","article-title":"The BET family in immunity and disease","volume":"6","author":"Wang","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0335","doi-asserted-by":"crossref","first-page":"16893","DOI":"10.1038\/s41598-023-44124-4","article-title":"Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson\u2019s disease","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.06.033_bib403","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/molecules29081857","article-title":"Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2012.12.006","article-title":"Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting","volume":"49","author":"Wu","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0350","first-page":"16","article-title":"Systematic review of machine learning in PTSD studies for automated diagnosis evaluation. Npj Mental Health","volume":"2","author":"Wu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molcel.2020.05.016","article-title":"Dysregulation of BRD4 function underlies the functional abnormalities of MeCP2 mutant neurons","volume":"79","author":"Xiang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0365","doi-asserted-by":"crossref","unstructured":"Zachariou, M., Loizidou, E.M., Spyrou, G.M., 2024. Immediate-Early Genes as Influencers in Genetic Networks and their Role in Alzheimer\u2019s Disease. bioRxiv 2024.03.29.586739. doi: 10.1101\/2024.03.29.586739.","DOI":"10.1101\/2024.03.29.586739"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.033_b0375","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41401-019-0256-2","article-title":"Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.033_b0380","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the Pathogenesis of Alzheimer\u2019s Disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0385","article-title":"Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models","volume":"298","author":"Zhang","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.06.033_b0370","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-024-03185-6","article-title":"Lactylation of histone by BRD4 regulates astrocyte polarization after experimental subarachnoid hemorrhage","volume":"21","author":"Zhang","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0390","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.molcel.2023.06.032","article-title":"Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation","volume":"83","author":"Zheng","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0395","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-023-02804-y","article-title":"The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.033_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137385","article-title":"Inhibition of BRD4 expression attenuates the inflammatory response and apoptosis by downregulating the HMGB-1\/NF-\u03baB signaling pathway following traumatic brain injury in rats","volume":"812","author":"Zhu","year":"2023","journal-title":"Neurosci. Lett."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:20:19Z","timestamp":1791465619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226004215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":88,"alternative-id":["S0306452226004215"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.033","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bromodomain protein 4 (BRD4) as a central epigenetic regulator in neuropsychiatric and neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}